跳至主要内容
临床试验/NCT05559411
NCT05559411招募中不适用

A Prospective Non-interventional Multicenter Cohort Study to Evaluate Different Imaging-guided Methods for Localization of Non-palpable Malignant Breast Lesions

European Breast Cancer Research Association of Surgical Trialists1 个研究点 分布在 1 个国家目标入组 7,416 人开始时间: 2023年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
7,416
试验地点
1
主要终点
Rate of intended target lesion and/or marker removal, independent of margin status on final histopathology (number of study participants with intended target lesion and/or marker removal, divided by the number of all study participants)

研究概览

简要总结

In the last decades, the proportion of breast cancer (BC) patients receiving breast-conserving surgery has increased steadily, reaching 70-80% in developed countries. Since positive resection margins are strongly associated with local recurrence risk, the goal of breast surgery is the complete tumor removal and most national and international guidelines recommend re-operation, either in form of re-excision or mastectomy, until clear margins have been reached. Re-operation rates vary widely, with population-based studies reporting a range of 15-35%, and the necessity for a second surgery can lead to increased patient anxiety, a delay in start of adjuvant treatment, worse cosmetic outcome and increased complication rates and costs. Therefore, re-operation rate has been included as a quality indicator in several countries.

Several imaging-guided techniques have been developed to guide removal of non-palpable breast lesions, the oldest one being preoperative wire placement under ultrasound or mammographic guidance, usually followed by radiography or ultrasound of removed tissue. Newer techniques, such as intraoperative ultrasound (IOUS), radioguided occult lesion localization (ROLL), radioactive seed localization (RSL), radar reflector-localization (RRL), magnetic seed localization (MSL), and radiofrequency identification (RFID) tags have been introduced as an alternative to wire-guided localization (WGL).

To date, comparative data on the rates of successful lesion removal, negative margins, re-operation rate and patient's comfort depending on the localization technique used are limited. Further, since some of these studies were funded by the manufacturer of the marker examined, a potential bias cannot be excluded. In the vast majority of the available studies, the patient's perspective with regard to discomfort and pain level has not been evaluated.

The aim of the proposed study is to comparatively evaluate different imaging-guided localization methods used for surgical removal of malignant breast lesions with regard to oncological safety and patient-reported outcomes.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Signed informed consent form
  • Malignant breast lesion requiring breast-conserving surgery and imaging-guided localization (either DCIS or invasive breast cancer; multiple or bilateral lesions and the use of neoadjuvant chemotherapy are allowed)
  • Planned surgical removal of the lesion using one or more of the following imaging-guided localization techniques:
  • Wire-guided localization
  • Intraoperative ultrasound
  • Magnetic localization
  • Radioactive seed localization
  • Radioguided Occult Lesion Localization (ROLL)
  • Radar localization
  • Radiofrequency identification (RFID) tag localization
  • Ink/carbon localization
  • Female / male patients ≥ 18 years old

排除标准

  • Patients not suitable for surgical treatment
  • Patients requiring mastectomy as first surgery
  • Surgical removal without imaging-guided localization

研究组 & 干预措施

Magnetic Localization

Radar Reflector Localization

Radiofrequency Localization

Radioactive Localization

Ink Localization

Luminomark Localization

Wire-guided Localization

Intraoperative Ultrasound

结局指标

主要结局

Rate of intended target lesion and/or marker removal, independent of margin status on final histopathology (number of study participants with intended target lesion and/or marker removal, divided by the number of all study participants)

时间窗: 2 years

Negative resection margin rates (defined as lesion removal with no invasive or non-invasive carcinoma on ink) at first surgery

时间窗: 2 years

Number of study participants with a negative resection margin, divided by the number of all study participants

次要结局

未报告次要终点

研究者

发起方
European Breast Cancer Research Association of Surgical Trialists
申办方类型
Network
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验